Cellico
South Korean medical-device startup (founded 2019; Pangyo/Seongnam, Gyeonggi) developing AR smart glasses for low vision (EyeCane) and an implantable artificial retina (“electronic eye”). Assignee of US11520154B2 (AR-glasses + intraocular-implant system) catalogued in visual-prosthesis-patents.
Company
- Founded 2019 (celebrating its fourth year as of late 2023); CEO Kim Jungsuk; based in the Pangyo Techno Valley (Seongnam); ~30 IP rights reported by 2023; listed as Samsung-accelerated in trade-show profiles; “social venture” positioning — microelectronic eye devices and vision-correction smart glasses for visually impaired patients.
Products & milestones
- EyeCane — AR glasses for low vision (AMD, glaucoma, diabetic retinopathy, retinal pigment degeneration, night blindness): a high-resolution camera plus real-time image processing that “replays” occluded areas of the field into the patient’s remaining peripheral vision (face recognition, reading, object finding); includes a big-data visual-field-test program for monitoring scotomas. Won CES Innovation Awards 2024 in three categories (Wearable Technologies, Digital Health, Accessibility & Aging Tech) after a CES 2023 award; Edison Awards in Health/Medical & Biotech (2023, 2024) and a 2025 finalist listing; developed in part with KBioHealth under a Korean MOTIE-supported project (2023–2025). Production and overseas launch were targeted for H1 2024 (company statements).
- Implantable artificial retina — the family behind US11520154B2: a sunglasses-form external unit (camera → image processing → lens microdisplay) that optically drives an intraocular stimulation implant, moving image processing out of the eye (KR/US/CN/EP family, all active; US granted 2022).
Caveats
- Company, funding and product status per Korean trade press and company statements; no peer-reviewed clinical validation captured; production timeline is a company target;
confidence: medium.
Related pages
- visual-prosthesis-patents — US11520154B2 entry
- retinal-prosthesis — technology category
- smart-glasses — wearables lineage (EyeCane is a non-implant low-vision device)
References
- AsiaTechDaily. “Cellico, ‘Smart AR Glasses,’ Wins CES 2024 Innovation Awards in Three Categories in the United States.” 21 November 2023. https://asiatechdaily.com/cellico-smart-ar-glasses-wins-ces-2024-innovation-awards-in-three-categories-in-the-united-states/
- Maeil Business Newspaper (MK). “EyeCane… Edison Awards 2025 Finalist.” 17 January 2025. https://www.mk.co.kr/en/it/11220617
- SightCity exhibitor profile (Seongnam; Samsung acceleration). Accessed 14 September 2026. https://sightcity.net/en/aussteller/cellico/
- Crunchbase company profile (implantable electronic eye / artificial retina). https://www.crunchbase.com/organization/cellico